Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan

doi:10.3748/wjg.14.7225

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2448)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

223

HTML

1916

Figures (1-3)

168

Tables (1-4)

141

Sum=2448

Dec 21, 2008 (publication date) through Apr 29, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 21, 2008; 14(47): 7225-7230
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7225

Full Size Figure Download Figure

Figure 2 The clinical parameters associated with SVR rate using univariate analysis. A: The relationship between EVR and SVR rate; B: The relationship between cumulative exposure to peg-IFN and SVR rate; C: The relationship between cumulative exposure to RBV and SVR rate.

Citation: Kogure T, Ueno Y, Fukushima K, Nagasaki F, Kondo Y, Inoue J, Matsuda Y, Kakazu E, Yamamoto T, Onodera H, Miyazaki Y, Okamoto H, Akahane T, Kobayashi T, Mano Y, Iwasaki T, Ishii M, Shimosegawa T. Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan. World J Gastroenterol 2008; 14(47): 7225-7230
URL: https://www.wjgnet.com/1007-9327/full/v14/i47/7225.htm
DOI: https://dx.doi.org/10.3748/wjg.14.7225